Jordan Winston

Ms. Jordan Winston


Research Focus & Metrics

Academic Career Length

11Years (2016-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
29 April 2017 in Molecules
Verified
Journal Article
Open access
PDF file
MAMina Aziz
Mina Aziz
DSDrew Sturtevant
Drew Sturtevant
JWJordan Winston
Jordan Winston
Eva CollakovaEva Collakova
Eva Collakova
JJJohn Jelesko
John Jelesko
KCKent Chapman
Kent Chapman
Urushiols are the allergenic components of Toxicodendron radicans (poison ivy) as well as other Toxicodendron species. They are alk-(en)-yl catechol derivatives with a 15- or 17-carbon side chain having different degrees of unsaturation. Although several methods have been developed for analysis of urushiols in plant tissues, the in situ localization of the different urushiol congeners has not been reported. Here, we report on the first analysis of urushiols in poison ivy stems by matrix-assisted laser desorption/ionization-mass spectrometry imaging (MALDI-MSI). Our results show that the urushiol congeners with 15-carbon side chains are mainly localized to the resin ducts, while those with 17-carbon side chains are widely distributed in cortex and vascular tissues. The presence of these urushiols in stem extracts of poison ivy seedlings was confirmed by GC-MS. These novel findings provide new insights into the spatial tissue distribution of urushiols that might be biosynthetically or functionally relevant.

14 June 2016 in bioRxiv
Verified
Preprint
Open access
PDF file
ACAlejandro Chavez
Alejandro Chavez
BPBenjamin W Pruitt
Benjamin W Pruitt
MTMarcelle Tuttle
Marcelle Tuttle
RSRebecca S Shapiro
Rebecca S Shapiro
RCRyan J Cecchi
Ryan J Cecchi
GCGeorge Church
George Church
Here we present a generalized method of guide RNA “tuning” that enables Cas9 to discriminate between two target sites that differ by a single nucleotide polymorphism. We employ our methodology to generate a novel in vivo mutation prevention system in which Cas9 actively restricts the occurrence of undesired gain-of-function mutations within a population of engineered organisms. We further demonstrate that the system is scalable to a multitude of targets and that the general tuning and prevention concepts are portable across engineered Cas9 variants and Cas9 orthologs. Finally, we show that the designed mutation prevention system maintains robust activity even when placed within the complex environment of the mouse gastrointestinal tract.